Buscar

Limitar los resultados
Buscar
Usar mi ubicación actual
Buscar

Tipo de servicio

Etiqueta

Número de resultados encontrados: 22
Use esta navegación adicional para ir a las páginas siguientes. Use las teclas de tabulación e Intro para navegar por el menú1 Página n.º 2 Navegar a la página siguiente Página 1 de 2
Saltee a 22 resultados encontrados. Página 1 de 2
    • Martes, 20 de abril de 2021

    Investigadores de Renown buscan participantes en el estudio de plasma de convaleciente

    Los médicos investigadores tratan de entender cómo responde el sistema inmunitario a la COVID-19 y crear un Nevada más saludable. Durante las primeras fases de la pandemia, el plasma de convalecencia se consideraba la única opción de tratamiento viable disponible para los pacientes con COVID-19. El plasma de convaleciente es el componente de la sangre de los pacientes recuperados que puede contener anticuerpos de COVID-19 que ayudan a combatir la infección. Desde entonces, los Institutos Nacionales de la Salud han elaborado directrices de tratamiento para la COVID-19 basadas en los datos de los estudios clínicos, y todavía se están realizando muchos estudios en todo el mundo que evalúan diversas opciones de tratamiento adicionales. El plasma de convaleciente tenía una gran demanda pero era difícil de localizar para los pacientes con COVID-19 en la zona del norte de Nevada. Austin Meegan, un auxiliar de enfermería de 24 años, fue hospitalizado y pasó semanas evitando la insuficiencia renal y pulmonar antes de enterarse de que cumplía los requisitos para recibir una transfusión de sangre experimental que parecía prometedora para el tratamiento de la COVID-19. Los médicos estimaron que Meegan solo tenía un 3 % de posibilidades de encontrar un donante compatible con su raro tipo de sangre. Thomas Gibson, un sobreviviente de la COVID-19 y residente de Texas con el mismo tipo de sangre, viajó a Reno para donar sus anticuerpos víricos y realizar una donación de plasma de convaleciente, la cual se cree que ayudó a salvar la vida de Meegan. Los investigadores clínicos y los científicos de Renown y de la Facultad de Medicina de la Universidad de Nevada, Reno (UNR Med) sabían que necesitaban crear mejores opciones para los pacientes y los médicos. Los investigadores clínicos desarrollaron un estudio para ayudar a otros pacientes como Austin, y solicitaron donaciones de pacientes recuperados de COVID-19 para que donaran su plasma de convaleciente. Los equipos de investigadores trataron de entender cómo responde el sistema inmunitario del cuerpo al virus a lo largo del tiempo, para ayudarles a desarrollar nuevos tratamientos para la COVID-19. “La capacidad del mundo para atravesar la crisis de la COVID dependerá de cuatro cosas: ciencia, tecnología, innovación y asociaciones”, dice el Dr. Tony Slonim, DrPH, presidente y director ejecutivo de Renown Health. “La capacidad del mundo para superar la crisis de la COVID dependerá de cuatro elementos: ciencia, tecnología, innovación y asociaciones, pero con UNR Med y nuestros socios, estamos haciendo grandes progresos en el avance de la investigación clínica que tiene el poder de salvar vidas y crear un estado de Nevada más saludable”. “Es tremendamente prometedor colaborar en la investigación clínica que no solo nos ayudará a entender mejor la enfermedad, sino que también ayudará a informar sobre el tratamiento para aquellos que combaten el COVID-19 que ha tenido un impacto tan devastador en los nevadenses, en nuestro país y en el mundo”, afirma Dean Thomas L. Schwenk, MD, de UNR Med. Renown, UNR Med y otros socios de atención médica del área colaboraron con Vitalant para recolectar plasma de donantes recuperados para un estudio sobre la eficacia del tratamiento. Los donantes elegibles tenían al menos 18 años, pesaban más de 110 libras y estaban sanos. Los donantes se habían recuperado completamente de un diagnóstico confirmado de COVID-19. Los coordinadores del proyecto en la Oficina de Investigación de Renown se vieron abrumados por el apoyo de la comunidad y las donaciones de plasma. Las asociaciones adicionales con el Distrito de Salud del Condado de Washoe, el estado de Nevada y la Oficina del Gobernador, Saint Mary’s Medical Center, Northern Nevada Medical Center, Carson Tahoe Health y VA Sierra Nevada Health Care System, junto con muchos proveedores de atención médica del área, ayudaron al equipo a alcanzar sus objetivos de inscribir a 120 participantes elegibles en el estudio. “Nuestro éxito en este estudio depende en gran medida del apoyo de nuestra gran comunidad, así como de la innovación y la colaboración demostradas por Renown y UNR Med”, afirmó Sara Healy, MD, MPH, investigadora principal del estudio y médica de enfermedades infecciosas pediátricas en Renown Children’s Hospital y UNR Med. “Estamos orgullosos de estar a la vanguardia respecto de la realización de investigaciones esenciales durante un tiempo tan importante de la historia, y esperamos que nuestra asociación se prolongue en el tiempo a medida que continuamos con esta importante labor”. “El control de la COVID-19 en nuestras comunidades depende de las pruebas. El estudio, que se está realizando para desarrollar una forma sensible, específica y más sencilla de recoger muestras (sangre), está avanzando en este campo y promete alcanzar nuestro objetivo común de tener la prueba de diagnóstico correcta para la situación clínica correcta en el momento correcto”, explica Mark Riddle, MD, DrPH, FISTM, investigador asociado del estudio, decano asociado de Investigación Clínica y profesor del Departamento de Medicina Interna e Investigación Médica de UNR Med. El equipo de investigación pide ahora a los residentes del área que participen en un estudio para analizar la eficacia de dos pruebas de detección de la COVID-19. Los participantes se someterán a dos análisis de sangre: uno de ellos consiste en una punción digital para obtener los resultados de una prueba rápida, y el otro consiste en una venopunción tradicional que confirma la presencia o ausencia de anticuerpos contra la COVID-19. Este estudio es una colaboración con InBios International, Inc. una empresa líder en biotecnología con sede en Seattle. Los investigadores buscan: Personas que han dado positivo para COVID-19 y que se han recuperado recientemente del virus. Los participantes del estudio deben estar en un período de entre 7 y 28 días posteriores al inicio de sus síntomas. Personas que recientemente hayan dado negativo para COVID-19 y nunca hayan dado positivo. Los interesados en participar en el estudio pueden ponerse en contacto con los coordinadores del proyecto en la Oficina de Investigación de Renown al (775) 982-3646, o por correo electrónico a covidplasmascreening@renown.org, de lunes a viernes, de 7:30 a.m. a 5:00 p.m. Se anima a las personas de entre 18 y 75 años con buena salud en general a que consideren la posibilidad de participar en este estudio en curso. No hay costo alguno por participar en este estudio y la participación es voluntaria. Su decisión de participar no afectará sus relaciones actuales o futuras con sus proveedores de atención médica, con el distrito de salud ni con la comunidad. Aquellos que decidan participar son libres de retirarse en cualquier momento. “El tiempo es vital cuando se trata de la COVID-19. Si podemos entregar los resultados de las pruebas a las personas y sus médicos de manera más oportuna, podremos hacer un diagnóstico más rápido del estado de salud de un paciente”, explica Christopher M. Kozlowski, MD, MHA, funcionario de Investigación Institucional de Renown y director médico/vicepresidente del Renown Institute for Heart & Vascular Health. “A medida que perfeccionamos la precisión de nuestras pruebas, aplicamos las pruebas de sensibilidad y especificidad para obtener resultados verdaderos negativos y verdaderos positivos. Esto proporciona a las personas resultados más oportunos y precisos y una atención de calidad mejorada”.     Acerca de Renown Health Renown Health es una red de atención médica integrada de administración local y sin fines de lucro que brinda servicios al norte de Nevada, Lake Tahoe y el noreste de California. Renown es uno de los mayores empleadores privados de la región y cuenta con una fuerza laboral de más de 7,000. Abarca tres hospitales de cuidados intensivos, un hospital de rehabilitación, el grupo médico y la red de atención de urgencias más integrales del área, y la compañía de seguro sin fines de lucro de propiedad local más grande de la región, Hometown Health. Renown tiene una larga trayectoria y un compromiso de larga data con la mejora de la atención y la salud de nuestra comunidad.     Acerca de la Facultad de Medicina de la Universidad de Nevada, Reno La Facultad de Medicina de la Universidad de Nevada, Reno (UNR Med), la primera facultad de medicina pública de Nevada, es una facultad basada en la comunidad, con un gran énfasis en la investigación y una visión a nivel estatal de un estado de Nevada saludable. Fundada en 1969, la UNR Med está mejorando la salud y el bienestar de todos los residentes de Nevada y sus comunidades mediante excelencia en la educación estudiantil, capacitación de posgrado y atención clínica, investigación con impacto local, nacional y global y una cultura de diversidad e inclusión. Para obtener más información, visite med.unr.edu.

    Leer más Acerca de Investigadores de Renown buscan participantes en el estudio de plasma de convaleciente

    • Miércoles, 05 de octubre de 2022

    Centro de Investigación Clínica recientemente ampliado en UNR Med fomenta la colaboración y la investigación con Renown Health

    Renown Health y University of Nevada, Reno School of Medicine (UNR Med) se enorgullecen en anunciar un espacio de investigación recientemente integrado y ampliado llamado Centro de Investigación Clínica (Clinical Research Center, CRC). Este espacio ofrece una ubicación física dinámica en el campus de la Universidad de Nevada, Reno, que apoya a la empresa de investigación UNR Med y Renown Health. “La asociación entre Renown Health y UNR Med realmente no conoce límites, y este Centro de Investigación Clínica es un ejemplo increíble de esa infinita posibilidad”, dijo Thomas Graf, MD, director ejecutivo interino de Renown Health. “Este nuevo espacio solo continuará expandiendo el acceso de nuestra comunidad a la investigación clínica como parte de la atención al paciente mientras proporciona los recursos necesarios para involucrar a nuestros estudiantes y apoyar un Nevada saludable”. Las capacidades de este espacio incluyen personal experimentado con conocimientos y habilidades en la puesta en funcionamiento de estudios de investigación clínicos y traslacionales no regulados por la FDA en una clínica de investigación centralizada de 5,470 pies cuadrados ubicada en el Centro de Medicina Molecular (Center for Molecular Medicine, CMM) de la Universidad. Este espacio de CRC proporciona recursos que incluyen: Una ubicación centralizada junto al espacio de laboratorio que permite la colaboración interdisciplinaria estratégica entre médicos y científicos básicos. Once habitaciones privadas para pacientes ambulatorios para visitas a la clínica de investigación. Dos estaciones de extracción de sangre. Áreas de consulta con el médico. Sala de conferencias para monitoreo y consultoría de ensayos. Asegurar el almacenamiento y la preparación del producto en investigación. Procesamiento y almacenamiento de muestras, incluidas centrífugas refrigeradas de encimera, refrigeradores y congeladores de 4°, -20° y -80° C. Las operaciones en torno a la investigación clínica se están volviendo más complejas, por lo que el crecimiento de la investigación clínica en nuestra comunidad requerirá experiencia y un espacio dedicado donde la investigación clínica se pueda realizar primero en un entorno de aprendizaje”, dijo Danielle Eaton, directora de Investigación Clínica de UNR Med y Renown Health. “Este centro de investigación clínica proporciona dicho espacio y personal experimentado donde estos estudios de investigación pueden completarse con éxito. El CRC proporciona un entorno de capacitación para estudiantes, residentes, cuerpo docente y personal profesional de investigación clínica que será necesario para llevar diagnósticos, tratamientos y preventivos de vanguardia a nuestra comunidad”. Conozca al equipo: Danielle Eaton, Directora médica de investigación clínica de UNR, Kristen Gurnea, Gerente de Investigación Clínica de Renown Health, Amber Emerson, Valerie Smith, gerente de proyectos de UNR Med, Annie Beach-Hills, gerente administrativa del UNR Med Center, Gina Castro, Michelle Mejia y Amil Trujillo-King, Coordinadores del estudio de UNR Med, Dr. John Westhoff, Presidente de Medicina Interna de UNR Med, Médico de medicina de emergencia, Dr. Sean Kandel, UNR Med Director asociado del programa de investigación para residentes, Profesor adjunto de Medicina Interna, Dr. Amneet Rai, Farmacéutica de investigación clínica de UNR Med, Dra. Kellie Watkins, Epidemiólogo clínico/gerente de datos/estadístico de UNR Med Como parte de la afiliación entre UNR Med y Renown Health, la Oficina de Investigación Clínica es parte de una Oficina de Investigación Clínica integrada, lo que permite que ambas entidades colaboren en los objetivos compartidos del programa de investigación. Este esfuerzo permite que los colegas se asocien en investigaciones clínicas y aprovechen la investigación y la prestación de atención médica de vanguardia a los nevadenses del norte. Acerca de Renown Health Renown Health es la red de atención médica integrada de administración local y sin fines de lucro más grande de la región, que presta servicios a Nevada, Lake Tahoe y el noreste de California. Con una fuerza laboral diversa de más de 7,000 empleados, Renown ha fomentado una cultura de excelencia, determinación e innovación de larga data. La organización se compone de un centro de urgencias, dos hospitales de cuidados agudos, un hospital infantil, un hospital de rehabilitación, un grupo médico y una red de atención de urgencias y Hometown Health, la compañía de seguros sin fines de lucro más grande de la región y de propiedad local, Hometown Health. Actualmente, Renown está inscribiendo participantes en el estudio genético de salud poblacional basado en la comunidad más grande del mundo, el Healthy Nevada Project®. Acerca de UNR Med La Universidad de Nevada, Reno School of Medicine (UNR Med), la primera escuela de medicina pública de Nevada, es una escuela de medicina comunitaria intensiva en investigación con una visión estatal para una Nevada saludable. Desde 1969, UNR Med ha capacitado a más de 3,900 estudiantes, residentes y becarios. La UNR Med continúa mejorando la salud y el bienestar de todos los residentes de Nevada y sus comunidades mediante excelencia en la educación estudiantil, capacitación de posgrado y atención clínica, investigación con impacto local, nacional y global, y una cultura de diversidad e inclusión. Para obtener más información, visite med.unr.edu.

    Leer más Acerca de Centro de Investigación Clínica recientemente ampliado en UNR Med fomenta la colaboración y la investigación con Renown Health

    • MyChart
    • Atención de urgencias
    • Vacuna contra la influenza

    Lo que debe saber sobre las vacunas contra la influenza

    Flu shots don’t just protect those who get vaccinated; they guard everyone, including your family and the community. Renown Health experts help us understand why everyone should get a flu shot, including children, pregnant women and older adults. Ways to Schedule Your Flu Shot Call Us! 775-982-5000 Urgent Care Appointments Renown Pharmacy Vaccinations Make an Appointment via MyChart Need a Doctor? Find One Now Flu Shot Information Whitney Robinson, Renown Health Infection Prevention Expert Chills, body aches, fever and congestion; getting the flu isn’t fun. When you get a flu shot, you’re not just protecting yourself, you’re also helping reduce the total flu cases and hospitalizations. The ideal time to get your flu shot is September through October. This timing allows the vaccine to provide the strongest protection during the length of flu season. However, getting the vaccine later is better than not at all as it's still flu season well into spring. Flu Symptoms In general, influenza (flu) is worse than the common cold and shares symptoms with COVID-19, causing mild to severe illness, and at times can lead to death. Symptoms include: Fever or feeling feverish/chills (not everyone will have a fever) Cough and/or sore throat Runny or stuffy nose Headaches, muscle or body aches Fatigue (tiredness) Vomiting and diarrhea, though this is more common in children than adults Who Needs a Flu Shot? Almost everyone. The Centers for Disease Control and Prevention (CDC) considers it the first and most crucial step in protecting against the flu virus. Therefore, they recommend the yearly flu shot for those six months of age and older. Does the Flu Shot Help with COVID-19? The short answer is no. However, flu vaccines can reduce the risks of flu illness and hospitalization. Therefore, it is crucial for you to get your flu shot to not only protect yourself and the community, but also to help conserve vital, local healthcare resources. CDC Resource: Who Needs a Flu Vaccine and When Kids, the Elderly and Flu Shots  Vanessa Slots, M.D., Renown Medical Group The flu is not a passing cold. It is a serious illness that takes lives every year and it happens like clockwork. The onset of flu season is fall and lasts through winter into the spring months. This lung illness is caused by viruses, with yearly outbreaks occurring worldwide. No one is immune, and anyone can catch  to the flu. Flu Signs and Symptoms Quick onset of fever Headache Body aches and fatigue along with respiratory symptoms including cough Sore throat and nose Who's at Risk for the Flu? Children and the elderly are at greater risk of complications from the flu, specifically toddlers less than two years old. At this age, their immunity is still developing. Seniors over 65 are also at increased risk because their immune systems have weakened with age. The severity of a child’s symptoms depends on age and prior exposure to the virus. With young children, for example, the flu is more problematic since they cannot talk and communicate their symptoms. As a result, children often experience higher fevers, which can lead to seizures or convulsions. This can be coupled with issues such as nausea, vomiting, diarrhea and poor appetite, all of which put children at risk of dehydration and other complications that can require hospitalization. An average of 20,000 children are hospitalized for flu each year. Pre-Existing Health Issues Ongoing health conditions including asthma, heart conditions, diabetes and more can intensify flu symptoms. Still, many children without risk factors can experience severe flu complications. CDC Resource: Flu Information for Parents Pregnant Moms and Flu Shots Tamsen Carson, PAC, Surgical First Assistant, OB/GYN, Renown Medical Group “During pregnancy, your immune system wards off infection for your baby, leaving you more susceptible to infection and adverse health conditions,” Tamsen explains. She   highly recommends flu shots for ALL women during pregnancy. You must receive the injected vaccine versus the live vaccine, a nasal spray, which can cause the flu to occur. Passing Flu Immunity on to Your Baby Also, remember that you will also be able to pass the immunity onto your baby if you breastfeed, which will protect your baby from the flu. CDC Resource: Flu Safety and Pregnancy

    Read More About What You Need To Know About Flu Shots

    • Atención del cáncer
    • Ensayos clínicos
    • Investigación y estudios

    Sobreviviente del cáncer de ovario cuenta cómo decidió probar con ensayos clínicos

    While there used to be three basic treatment options for cancer -- surgery, radiation and chemotherapy, or a combination of the three -- there's a fourth option: clinical trials. Here, a Renown patient shares her successful battle with ovarian cancer, aided by a clinical trial. Shari Flamm's battle with ovarian cancer began in 2011. She was experiencing prolonged bleeding, irregular thyroid levels and anemia and was scheduled to undergo a hysterectomy. Before the surgery, her gynecologist ran routine tests to check for cancer as a precautionary measure. All tests were negative for cancer, expect her CA 125 test. A CA 125 test measures the amount of the protein CA 125 (cancer antigen 125) in the blood. In some cases, a CA 125 test may be used to look for early signs of ovarian cancer in women with a very high risk of the disease. In most laboratories, the normal level is 0 to 35 units/ml. Flamm's CA 125 level was 121. As Flamm can attest, early diagnosis played a key role in her battle with ovarian cancer. September is Gynecologic Cancer and Ovarian Cancer Awareness Month – an important time to learn the signs, symptoms and risk factors of this type of cancer so your doctor can diagnosis the disease as early as possible. Ovarian Cancer: Round One Despite the elevated CA 125 results, her doctor recommended they move forward with the hysterectomy. But when surgery began, doctors discovered a mass. She had stage 4 cancer. The procedure was halted, the mass was biopsied and she was immediately seen by Dr. Peter Lim of the The Center of Hope. Following diagnosis, Flamm underwent surgery with Dr. Lim to remove the cancer, which had spread to part of diaphragm, spleen, colon and other organs. Three months after surgery, Flamm had recovered enough to start six rounds of chemotherapy in her hometown of Carson City. She continued working at a doctor's office during her treatment, and was grateful for Dr. Lim’s ability to co-manage her care so she could stay close to work and family. “To me, chemo was the scariest part because I didn’t like feeling sick,” Flamm says. Thankfully, her body responded well to the treatments and she was back to the things she loved. “I stated working out at the gym, even if it was only for 10 minutes,” she says. She also stayed positive by spending time with her grandchildren, attending a San Jose Sharks hockey game, going for walks and enjoying concerts. Ovarian Cancer: Round Two In November 2014, Flamm had a cancer check-up. That’s when doctors discovered three cancerous tumors. For this round, Flamm choose another treatment option -- clinical trials at Renown Institute for Cancer. Clinical trials are the studies that test whether drugs work, and inform doctors' decisions about how to treat their patients. Flamm participated in a clinical trial that featured oral-targeted therapy stronger than IV chemotherapy. The hope was for the drug to shrink her tumors, however the result was stabilization -- meaning the lumps weren’t growing or spreading. The best part of the clinical trial, Flamm says, was the constant monitoring. Between the CT scans every six weeks, a heart scan every three months and monthly doctor visits, she was confident that if the cancer started growing or spreading, her healthcare team would catch it right away. For Flamm, the benefits of the clinical trial included less hair loss, less fatigue and more time to focus on what’s important in her life -- her family. “I decided I wasn’t going to be that sick grandma on the couch with cancer,” Flamm says. After taking the oral medication for one year, Flamm developed a rash and discontinued treatment due to discomfort. Clinical Trials, Setbacks and Survival In June 2016, two of the three tumors began to grow and had to be surgically removed. Despite the setback, Flamm was determined to maintain a positive outlook. "You have to stay positive because cancer feeds off anger, depression and stress," Flamm says. Flamm was released to go home with clear margins, meaning the tumors were removed and are surrounded by a rim of normal tissue that does not have cancerous cells. Flamm says her outlook on life has changed drastically since her first cancer diagnosis. “Your whole mentality changes when cancer disturbs your life," Flann says. "The things that weren’t important, are now ever so important. I’m a lot calmer now,” Flamm says.

    Read More About Ovarian Cancer Survivor Shares Decision to Try Clinical Trial

    • Farmacia
    • Consumo de drogas
    • Medicamentos

    Medicamentos genéricos: lo que debe saber sobre ellos

    Without a doubt, taking medications can not only be expensive, but also confusing. In the United States, generic prescriptions are widely used, with 9 out of 10 people choosing them over a name brand. Pharmacists are a great resource to help us understand the benefits and side effects of any medication. We asked Adam Porath, PharmD, Vice President of Pharmacy at Renown Health, to answer some common questions about generic drugs. What is a generic drug? A generic drug has the same active ingredients of brand-name drugs. Brand-name drugs have a patent (special license) protecting them from competition to help the drug company recover research and development costs. When the patent expires other manufacturers are able to seek approval for a generic drug. However, the color, shape and inactive elements may be different. Per the U.S. Food & Drug Administration (FDA), a generic medicine works in the same way and provides the same clinical benefit as its brand-name version. Why do they cost less? Generic drug makers do not have the expense of costly development, research, animal and human clinical trials, marketing and advertising. This savings is passed on to the public. Also after a patent expires, several companies will compete on a generic version of a drug, further driving down prices.

    Read More About Generic Drugs – What You Need to Know About Them

    • Ensayos clínicos
    • Investigación y estudios

    ¿Qué significa participar en un estudio clínico?

    Participating in a clinical trial is voluntary and a personal choice. Clinical trials are research studies that involve people and are an important part of patient care. What is a clinical trial?  Clinical trials are research studies that involve people, and they are an important part of patient care. There are several different types of clinical trials; some are designed to understand trends in a disease or identify better ways to diagnose a condition, while others determine if a new treatment is safe and works when treating, improving or preventing a health condition. There are over 400,000 clinical trials currently being conducted in the United States, and even more across the world. This includes health conditions such as heart failure, cancer, Parkinson’s Disease, respiratory conditions like COPD, common infections, cystic fibrosis, and many more. Clinical trials lead the healthcare industry to new discoveries that contribute to reliable and exact care, improving healthcare quality and saving lives. Clinical trials are conducted by a team of researchers, including doctors, pharmacists and clinical research coordinators. These research teams are highly skilled in their specialty areas, often providing traditional patient care and seeing research patients in the same day. These teams are responsible for making sure the clinical trial is completed correctly, and their patients are their top priority. Why should I consider participating in a clinical trial? Participating in a clinical trial is voluntary and a personal choice. There are many reasons why patients decide to get involved in clinical research. While many clinical trials are designed for patients who have a certain health condition, many studies also ask healthy volunteers to contribute in order to compare health outcomes. Clinical trials are also for patients at all different stages of their diagnosis. Depending on the specific study, the patient may receive access to a new cutting-edge treatment before it is widely available. When patients join a clinical trial, the research team becomes a health partner dedicated to their health and well-being. When patients join a clinical trial, they make an informed decision in their healthcare by weighing all available options in addition to routine treatments. Research participants know that they are contributing meaningfully and helping other patients like them. Where can I find more information about clinical trials at Renown Health? Renown Health’s mission is to make a genuine difference in the health and well-being of the communities we serve. Renown’s clinical trial portfolio offers leading care options to patients in northern Nevada, close to home, in a variety of specialties. Contact the Renown Clinical Research Office for more information on clinical trials available to you!

    Read More About What Does It Mean to Participate in a Clinical Trial?

    • Atención del cáncer
    • Testimonio de paciente
    • Ensayos clínicos

    Un diagnóstico de cáncer y una mudanza a Reno

    Michael Millman was all set to move to Reno from the Bay Area when he noticed a pimple-like growth on his forehead, and he decided to get biopsied "just in case." It was July 2020, less than six months into the COVID-19 pandemic, when Michael got the call that the biopsy came back cancerous. He was in shock. Still living in the Bay Area at the time, he immediately scheduled to have the basal cell carcinoma removed in August. After the removal, he thought he was in the clear, but a few months later, Michael noticed that his lymph nodes felt weird, and he even cut himself shaving because of some persistent swelling in the area. Given his recent history of skin cancer, Michael immediately scheduled an appointment with a specialist in the Bay Area. "I met with an ear, nose and throat doctor who suggested a fine needle biopsy of my lymph nodes, tongue and an MRI, both with and without contrast," Michael said. "I remember feeling dreadful and that I couldn't believe this was happening yet again." A Hard Decision Michael's squamous cell carcinoma, determined by the pathology report to be significantly influenced by the HPV virus, had metastasized to his lymph nodes on both sides of his neck, and his doctor said it could be stage four cancer. He remembers feeling like he was in quicksand, unsure if he should follow through with his move to Reno, or stay in the Bay Area for treatment. By now, it was early December 2020, and hospitals in the Bay Area and across the world were at limited capacity due to COVID-19. But, in what Michael describes as a positive twist of fate, the San Francisco ear, nose and throat provider he had seen about his biopsy results mentioned that he knew many providers in the oncology department at Renown, including Abhinand Peddada, MD. The San Francisco provider called Dr. Peddada's office with a referral, and Michael even remembers that Renown called him to hear more about his diagnosis before he even got the chance to call them "To be honest, I was feeling shut out in the Bay Area, and Dr. Peddada said he could help me expedite the treatment process," Michael said. "I finally felt a sense of relief." And so began Michael's 7-week chemoradiation cancer treatment program at Renown.

    Read More About A Cancer Diagnosis and a Move to Reno

    • Vacuna contra la influenza
    • Salud infantil

    Padres, sus hijos necesitan vacunas contra la gripe. Este es el por qué

    Vanessa Slots, MD, of Renown Medical Group – Pediatrics, explains why getting a flu shot each season can save lives—especially true for the very young and elderly. Why Kids Need Flu Shots The flu is not a passing cold. It is a serious illness that takes lives every year. And this year, flu activity is increasing late in the season.  And it happens like clockwork — the onset of an influenza epidemic as fall transitions into winter, and lasts into the spring months. This acute respiratory illness is caused by influenza A or B viruses with yearly outbreaks occurring worldwide. No one is immune, and everyone is susceptible to the flu. Flu Signs and Symptoms: Abrupt onset of fever Headache Body aches and fatigue along with respiratory-tract symptoms including cough Sore throat and an irritated nose Who’s at Risk? Once again: Everyone is susceptible, but children and the elderly are at greater risk of complication from influenza, specifically toddlers less than 2 years. At this age, immunities are underdeveloped. Seniors over 65 are also at increased risk because their immune systems have weakened with age. The severity of a child’s symptoms depend on age and prior exposure to the virus. And with young children, flu is more problematic, since they cannot verbalize certain symptoms like body aches and headaches. As a result, children often experience higher fevers, which can lead to seizures or convulsions. Coupled with gastrointestinal issues such as nausea, vomiting, diarrhea and poor appetite, children are at risk of dehydration and other complications from the virus that can require hospitalization. In fact, an average of 20,000 children are hospitalized from flu each year. Pre-Existing Health Issues Health conditions, including but not limited to asthma, cystic fibrosis, heart conditions, cerebral palsy, epilepsy or diabetes, can intensify flu symptoms. Still, a substantial number of children with none of these risk factors experience severe complications from the flu. How to Protect Your Child from the Flu The best way to guard against influenza is with a flu shot. Children and adults should get the flu vaccine before flu season kicks in — usually by the end of October. Shots are provided as long as flu viruses are circulating and the vaccine is in supply.

    Read More About Parents, Your Kids Need Flu Shots. Here's Why.

    • Ensayos clínicos

    5 conceptos erróneos principales sobre los ensayos clínicos

    There are many misconceptions about clinical research, so we have unpacked a few common myths we hear to help you make an informed decision in your healthcare. Misconception #1: If I join a clinical trial, I’ll just be a guinea pig. Quite the opposite is true! Through honest and respectful conversation, we ensure all participants are informed of the benefits and risks associated with the clinical trial during the informed consent process. Being in a clinical trial is voluntary, and we respect our patients’ decision to join or decline to participate in the clinical trial. You can always change your mind at any time as well. When patients join a clinical trial, they receive an additional team of healthcare professionals, including additional physicians, pharmacists and research coordinators, dedicated to their safety and well-being. This means that clinical trial participants often receive more support than they would in the standard treatment setting. Misconception #2: Clinical trials are too dangerous because they use new treatments that haven’t been tested. We recognize that there are different levels of risk associated with participating in a clinical trial depending on the type of study. However, new treatments are only reviewed through clinical trials after they have gone through extensive testing. New treatments that do not show promising results for safety and potential benefit during laboratory testing do not receive approval to begin clinical trials. Your research team reviews any expected benefits and risks identified from previous studies during the informed consent process, as well as any updates that occur throughout the duration of the clinical trial. The research team stays in close contact with you during the entire process, documenting and treating any side effects that you experience for both your safety and the safety of participants like you. Misconception #3: I don't want to join a trial because I could be wasting my time receiving a placebo. A placebo is a substance that has no therapeutic effect, sometimes called a “sugar pill.” Participants who receive a placebo during a clinical trial are very important, helping researchers definitively determine the specific good and bad effects of the new medication. Many clinical trials that involve a placebo also offer what is called an open label extension or cross-over study. Cross-over studies ensure that anyone taking the placebo can begin receiving the new medication, often for several years. Cross-over studies help clinician researchers understand the long-term effects of a medication while also giving patients free access to novel care for several months and even years.

    Read More About Top 5 Misconceptions About Clinical Trials

    • Investigación y estudios
    • Ensayos clínicos

    Cómo la afiliación a UNR Med afecta la investigación clínica de Renown

    The University of Nevada, Reno School of Medicine (UNR Med) and Renown Health affiliated in June of 2021. First Integrated Health System The University of Nevada, Reno School of Medicine (UNR Med) and Renown Health affiliated in June of 2021. This agreement established Nevada’s first integrated health system with missions in education, patient care, and clinical research. While there was extensive media coverage regarding the historic partnership in general, there is less information regarding the important impact to the community. In terms of clinical research, the potential benefits are endless. The School of Medicine has a very successful program in molecular bio sciences. That means they have a plethora of brilliant minds working on the smallest components of life related to body systems and disease. With the affiliation, there is a distinct opportunity to bridge some of these important findings happening on campus and translate them into care protocols for the patients seen in the community. Making connections between the cellular basics to the physical manifestations of conditions is a key opportunity of the affiliation. Additionally, cooperative funding models for projects that fit in the translational research bucket are available to these researchers. Renown and UNR Med are poised to provide potentially cutting-edge treatments with bench to bedside research. Expanding Clinical Trials Perhaps the most important outcome of the affiliation is access to novel treatments via clinical trials. In the coming years, Renown and UNR Med will work to expand their clinical trial portfolio in an effort to provide a clinical trial option for many diseases in addition to standard of care. This endeavor will allow patients to make an informed choice about their healthcare. With novel treatments available right here in Reno, people won’t have to travel to other research institutions for similar care. This eases a tremendous potential burden on patients and families alike navigating complex illnesses like cancer. The affiliation is exciting and provides many opportunities for clinicians (present and future) and the community. Renown's Clinical Research Office is thrilled to be a part of this historic time and are enthusiastic to communicate our successes and opportunities to the community. We sincerely look forward to contributing to the vision of “a healthy Nevada.”

    Read More About How the UNR Med Affiliation Impacts Renown's Clinical Research

    • Atención cardíaca
    • Ensayos clínicos
    • Investigación y estudios

    Cómo controlar su presión arterial alta no controlada

    Renown Health, the region's leading cardiology care provider, is offering a clinical trial for eligible patients struggling to control their high blood pressure. Nearly half of adults (119.9 million) in the United States have hypertension, or blood pressure that is higher than normal. Hypertension can put you at risk of other life-threatening disease, such as a heart attack or stroke. There are methods that cardiologists use to manage high blood pressure, but only 1 in 4 adults with hypertension (27.0 million) have their blood pressure under control.* Some patients with high blood pressure experience resistant hypertension, which does not respond well to multiple antihypertensive medications given at the same time. This means that there are many important opportunities for healthcare professionals to explore new ways to treat hypertension.  At Renown Health, we lead the region in cardiology care with our technological expertise and patient-centered approach. That is why our cardiology team is partnering with the Renown Research Office to offer the RADIANCE Continued Access Protocol (RADIENCE CAP) clinical trial to eligible patients. RADIANCE CAP is a non-randomized study designed to allow for continued access to ultrasound renal denervation therapy via the Paradise System, and to allow for the on-going collection of safety and effectiveness data in patients with uncontrolled hypertension despite the prescription of antihypertensive medications. The body’s complex communication system between the brain, heart and kidneys can sometimes become overactive, increasing your blood pressure through messages in the nervous system. Renal denervation is a minimally-invasive procedure which reduces activity from the nerves in your kidneys to lower blood pressure.  This is the third in a series of renal denervation clinical trials Renown Health has offered to patients with resistant hypertension over the last several years, with over 40 local participants.  “All the participants that I have had the pleasure to work with on these studies are very excited and grateful to have this option for helping control their blood pressure” states Lisa English, Lead Clinical Research Coordinator for Cardiology studies at Renown Health. “I love getting to know each one of them and helping on their healthcare journey. We have an amazing team of providers and staff at Renown that go out of their way to make patients experiences positive and the studies successful.” Dr. Michael Bloch, Cardiologist and Principal Investigator for the RADIANCE CAP study at Renown Health’s Institute for Heart and Vascular Health adds, “Despite lifestyle modifications like diet and exercise and the widespread availability of effective and well-tolerated medications, approximately 50% of all people with hypertension have inadequate blood pressure control putting them at risk for stroke, heart failure and kidney disease. As a one-time durable procedure, renal denervation with the Paradise endovascular system from ReCor Medical, Inc. may help millions of patients improve their blood pressure control without necessarily needing to increase their medications.” Our teams of expert providers and researchers are here to support you on your healthcare journey. Talk to your provider about the RADIANCE CAP clinical trial at your next appointment to see if participation may be right for you.

    Read More About Managing Your Uncontrolled High Blood Pressure

Número de resultados encontrados: 22
Use esta navegación adicional para ir a las páginas siguientes. Use las teclas de tabulación e Intro para navegar por el menú1 Página n.º 2 Navegar a la página siguiente Página 1 de 2
Saltee a 22 resultados encontrados. Página 1 de 2